Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.

BioTime Inc.

Started by caliban , Mar 25 2011 01:11 AM

economics regenerative medicine stemells tissue engineering regmed

Please log in to reply

777 replies to this topic

#361 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 03 December 2013 - 09:56 AM

Asterias Biotherapeutics Inc files registration statement for public offering ...
MENAFN.COM - 2 hours ago

Asterias Biotherapeutics Inc is a subsidiary of BioTime Inc (nyse mkt:BTX), a biotechnology company engaged in research and product development in the field of regenerative medicine.

View the full article

#362 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 04 December 2013 - 01:52 PM

BioTime, Inc. : BioTime's CEO, Dr. Michael West to Moderate Session on ...
4-traders (press release) - 2 hours ago

BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, announced that BioTime's CEO, Dr. Michael West will lead a session titled "From Mapping the Genome to Mapping the Embryome: The Urgent Need for an International Initiative" today at the ...

View the full article

#363 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 04 December 2013 - 01:52 PM

BioTime, Inc. : BioTime's CEO, Dr. Michael West to Moderate Session on ...
4-traders (press release) - 9 hours ago

View the full article

#364 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 06 December 2013 - 02:15 PM

Vista Partners Publishes December 2013 Macroeconomic & Investment Newsletter
Wall Street Journal - 3 hours ago

Tec Limited, Ohr Pharmaceutical, Inc. (NASDAQ: OHRP), BioTime, Inc., Redhawk Resources, Inc., The Alkaline Water Company Inc. Targeted Medical Pharma Inc., and Power Solutions International Inc. (NASDAQ: PSIX).

View the full article

#365 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 06 December 2013 - 09:11 PM

BioTime, Inc. : LifeMap Sciences, a Subsidiary of BioTime, Announces Release ...
4-traders (press release) - 4 minutes ago

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.11.

View the full article

#366 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 06 December 2013 - 09:11 PM

BioTime, Inc. : LifeMap Sciences, a Subsidiary of BioTime, Announces Release ...
4-traders (press release) - 3 hours ago

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.11.

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards ... - HispanicBusiness.com

View the full article

#367 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 04 December 2013 - 01:52 PM

BioTime, Inc. : BioTime's CEO, Dr. Michael West to Moderate Session on ...
4-traders (press release) - Dec 4, 2013

View the full article

#368 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 06 December 2013 - 02:15 PM

Vista Partners Publishes December 2013 Macroeconomic & Investment Newsletter
Wall Street Journal - Dec 6, 2013

View the full article

#369 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 04 December 2013 - 01:52 PM

BioTime's CEO, Dr. Michael West to Moderate Session on Mapping the Cellular ...
HispanicBusiness.com - Dec 4, 2013

ALAMEDA, Calif. --(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, announced that BioTime's CEO, Dr.

View the full article

#370 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 11 December 2013 - 08:15 AM

California's Stem-Cell Quest Races Time as Money Dwindles
Bloomberg - 8 hours ago

Geron later sold its stem-cell program for $35 million in cash and stock to Alameda, California-based Biotime Inc. (BTX). Nevertheless, the stem-cell agency's go-commercial push is warranted, said Hank Greely, a professor specializing in biomedical ...

View the full article

#371 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 12 December 2013 - 03:45 PM

3 Reasons Behind Geron Corporation (GERN)'s Rebound
Next iPhone News - Dec 12, 2013

In October 2013, Geron sold its entire embryonic stem cell pipeline to BioTime, Inc. (NYSEMKT:BTX)'s new subsidiary Asterias Biotherapeutics, in exchange for a 21.4% stake in Asterias and undisclosed royalties on commercialized treatments ...

View the full article

#372 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 11 December 2013 - 08:15 AM

California's $3 Billion Stem-Cell Quest Races as Money Dwindles
Businessweek - Dec 11, 2013

Geron later sold its stem-cell program for $35 million in cash and stock to Alameda, California-based Biotime Inc. (BTX:US).

View the full article

#373 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 17 December 2013 - 03:22 PM

Is Geron Corporation (GERN) Finally Onto Something?
Next iPhone News - 57 minutes ago

Geron Corporation (NASDAQ:GERN) has continued reshaping itself this year by closing a deal to sell its human embryonic stem cell assets to BioTime, Inc. (NYSEMKT:BTX), and closing its research facility in California last April. To save money, Geron ...

View the full article

#374 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 20 December 2013 - 02:03 PM

BioTime, Inc. : BioTime Reports Isolation of Novel Brain-Associated Cells From ...
4-traders (press release) - 16 minutes ago

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine reported today the publication of a peer-reviewed scientific paper on the successful generation of human cells with markers ...

View the full article

#375 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 20 December 2013 - 02:03 PM

BioTime, Inc. : BioTime Reports Isolation of Novel Brain-Associated Cells From ...
4-traders (press release) - 10 hours ago

View the full article

#376 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 23 December 2013 - 01:52 PM

BioTime, Inc. : BioTime's Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.7 ...
4-traders (press release) - 1 hour ago

23, 2013-- BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure) today announced that Cell Cure has been awarded a grant for 2014 of 6.1 million Shekels (approximately $1.74 million) from Israel's Office of the Chief ...

BioTime's Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.7 Million Grant ... - Business Wire (press release)

View the full article

#377 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 20 December 2013 - 02:03 PM

BioTime, Inc. : BioTime Reports Isolation of Novel Brain-Associated Cells From ...
4-traders (press release) - Dec 20, 2013

View the full article

#378 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 02 December 2013 - 03:56 PM

BioTime (BTX) Trades Flat Amid $15M Equity Offering
StreetInsider.com (subscription) - Dec 2, 2013

BioTime, Inc. (NYSE: BTX) is flat amid news the company filed a registration statement with the SEC or an underwritten public offering of up to $15,000,000 of units with each unit consisting of one share of Series B common stock and one redemption right.

View the full article

#379 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 31 December 2013 - 05:48 AM

BioTime, Inc. : BioTime Reports Publication of Peer-reviewed Scientific Paper
4-traders (press release) - 3 hours ago

BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, reported the publication of a peer-reviewed scientific paper on the successful generation of human cells with markers of particular cell ...

View the full article

#380 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 31 December 2013 - 05:15 PM

Insider Buying: Neal Bradsher Acquires 300042 Shares of BioTime Stock (BTX)
Ticker Report - 2 hours ago

BioTime Inc. logo BioTime (NYSE:BTX) Director Neal Bradsher bought 300,042 shares of the company's stock on the open market in a transaction dated Monday, December 30th.

View the full article

#381 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 31 December 2013 - 05:58 AM

BioTime, Inc. : BioTime Reports Publication of Peer-reviewed Scientific Paper
4-traders (press release) - 17 hours ago

View the full article

#382 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 31 December 2013 - 05:58 AM

BioTime, Inc. : BioTime Reports Publication of Peer-reviewed Scientific Paper
4-traders (press release) - Dec 31, 2013

View the full article

#383 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 02 January 2014 - 01:52 PM

Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Leases ...
Business Wire (press release) - 3 hours ago

MENLO PARK, Calif. & ALAMEDA, Calif.--(BUSINESS WIRE)--Asterias Biotherapeutics, Inc. and BioTime, Inc. (NYSE MKT: BTX) today announced that Asterias has executed a long term lease for a research, development and manufacturing facility to house ...

View the full article

#384 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 30 December 2013 - 10:30 AM

BioTime, Inc. : Regenerative Medicine to Publish Paper on BioTime's Isolation ...
4-traders (press release) - Dec 30, 2013

BioTime, Inc. , a biotechnology company that develops and markets products in the field of regenerative medicine, reported the publication of a peer-reviewed scientific paper in Regenerative Medicine on the generation of human cells with markers of ...

View the full article

#385 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 04 January 2014 - 10:30 AM

Asterias leases facilities for product R&D, manufacturing
pharmabiz.com - 50 minutes ago

Asterias Biotherapeutics, Inc. a subsidiary of BioTime, Inc., has executed a long term lease for a research, development and manufacturing facility to house all of its cell therapy product development activities.

Asterias Biotherapeutics leases facilities for expanded product development ... - Pharmaceutical Business Review

View the full article

#386 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 05 January 2014 - 02:37 PM

Forecast 2014: The Human Transformation Revolution
Gold Seek - 7 hours ago

This is why my colleague Patrick Cox (who writes our Transformational Technology Alert letter) and I volunteered to participate in a pilot project conducted by BioTime, Inc. We both donated cells taken from inside our left arms. Those cells were then ...

View the full article

#387 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 06 January 2014 - 05:37 AM

BioTime, Inc. : BioTime's Subsidiary Cell Cure Neurosciences Receives Grant ...
4-traders (press release) - 3 hours ago

BioTime, Inc. and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure) announced that Cell Cure has been awarded a grant for 2014 of 6.1 million Shekels (approximately $1.74 million ) from Israel's Office of the Chief Scientist (OCS) to help finance ...

View the full article

#388 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 02 January 2014 - 01:52 PM

Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Leases ...
Business Wire (press release) - Jan 2, 2014

View the full article

#389 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 06 January 2014 - 05:37 AM

BioTime, Inc. : BioTime's Subsidiary Cell Cure Neurosciences Gets Grant from ...
4-traders (press release) - Jan 6, 2014

View the full article

#390 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 13 January 2014 - 02:03 PM

BioTime Reports Results of Clinical Safety Trial of Renevia™
Wall Street Journal - 1 hour ago

BioTime, Inc. (NYSE MKT: BTX) today announced the completion of a safety trial evaluating Renevia™, a proprietary injectable matrix designed to facilitate the stable engraftment of transplanted cells, and the results of that study.

View the full article

Back to Ventures & Markets

Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

Science & Health → Supplements → Senolytics → D+Q restore regeneration in Killfish Started by ambivalent , 14 Jul 2023 dasatinib quercetin and 3 more...	0 replies 2,115 views	ambivalent 14 Jul 2023
Round Table Discussion → Business → Ventures & Markets → Longeveron Started by ImmInst , 16 Jun 2016 longeveron, stem cell and 1 more...	2 replies 2,630 views	kurt9 02 Jun 2020
Community → News & Resources → News → Longevity Industry in California Landscape Started by Engadin , 03 Jun 2019 longevity industry, california and 8 more...	0 replies 2,027 views	Engadin 03 Jun 2019
Community → News & Resources → News → Rejuvenating Aged Brains by Waking Up Dormant Stem Cells Started by Engadin , 04 Mar 2019 regenerative medicine, aged brain and 1 more...	0 replies 2,136 views	Engadin 04 Mar 2019
Science & Health → Supplements → Economics and Supplements: What to take on a budget? Started by Brian81 , 18 Mar 2018 economics, supplements, budget	4 replies 4,054 views	Nate-2004 20 Mar 2018

5 user(s) are reading this topic

0 members, 5 guests, 0 anonymous users

Google Sign in options

BioTime Inc.

#361 ImmInst

#362 ImmInst

#363 ImmInst

sponsored ad

#364 ImmInst

#365 ImmInst

#366 ImmInst

#367 ImmInst

#368 ImmInst

#369 ImmInst

#370 ImmInst

#371 ImmInst

#372 ImmInst

#373 ImmInst

#374 ImmInst

#375 ImmInst

#376 ImmInst

#377 ImmInst

#378 ImmInst

#379 ImmInst

#380 ImmInst

#381 ImmInst

#382 ImmInst

#383 ImmInst

#384 ImmInst

#385 ImmInst

#386 ImmInst

#387 ImmInst

#388 ImmInst

#389 ImmInst

#390 ImmInst

Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

D+Q restore regeneration in Killfish

Longeveron

Longevity Industry in California Landscape

Rejuvenating Aged Brains by Waking Up Dormant Stem Cells

Economics and Supplements: What to take on a budget?

5 user(s) are reading this topic

Ad Notice